Follow the people · Insider
David Malcom Rodman
David Malcom Rodman files insider transactions with the SEC as a chief medical officer of Mineralys Therapeutics (MLYS). We hold 32 disclosed purchases and sales filed since 6 July 2016, 9 of them in the last 90 days.
- Files forMLYS
- Disclosed buys and sells32 in all, 9 in the last 90 days
- Last disclosure12 August 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 9 February 2023 — 10 August 2026Chief Medical Officer · Mineralys Therapeutics (MLYS)312 Form 4 lines · source: SEC Form 4
- Filed 1 July 2016 — 4 January 2017Exec Vice President and CMO · Nivalis Therapeutics (NVLS)10 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 2,170 shares of Mineralys TherapeuticsSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- ▼ sold on the open market 2,170 shares of Mineralys TherapeuticsSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- exercised options over 2,170 shares of Mineralys Therapeutics (a derivative holding)SEC Form 412 August 2026Stock Option · traded 10 August 2026 · filed 12 August 2026
- exercised options over 416 shares of Mineralys TherapeuticsSEC Form 420 July 2026Common Stock · traded 17 July 2026 · filed 20 July 2026
- ▼ sold on the open market 416 shares of Mineralys TherapeuticsSEC Form 420 July 2026Common Stock · traded 17 July 2026 · filed 20 July 2026
- exercised options over 416 shares of Mineralys Therapeutics (a derivative holding)SEC Form 420 July 2026Stock Option · traded 17 July 2026 · filed 20 July 2026
- exercised options over 3,542 shares of Mineralys TherapeuticsSEC Form 415 July 2026Common Stock · traded 13 July 2026 · filed 15 July 2026
- exercised options over 4,167 shares of Mineralys TherapeuticsSEC Form 415 July 2026Common Stock · traded 13 July 2026 · filed 15 July 2026
- exercised options over 6,349 shares of Mineralys TherapeuticsSEC Form 415 July 2026Common Stock · traded 13 July 2026 · filed 15 July 2026
- ▼ sold on the open market 14,058 shares of Mineralys TherapeuticsSEC Form 415 July 2026Common Stock · traded 13 July 2026 · filed 15 July 2026
- ▼ sold on the open market 6,349 shares of Mineralys TherapeuticsSEC Form 415 July 2026Common Stock · traded 15 July 2026 · filed 15 July 2026
- exercised options over 3,542 shares of Mineralys Therapeutics (a derivative holding)SEC Form 415 July 2026Stock Option · traded 13 July 2026 · filed 15 July 2026
- exercised options over 4,167 shares of Mineralys Therapeutics (a derivative holding)SEC Form 415 July 2026Stock Option · traded 13 July 2026 · filed 15 July 2026
- exercised options over 6,349 shares of Mineralys Therapeutics (a derivative holding)SEC Form 415 July 2026Stock Option · traded 13 July 2026 · filed 15 July 2026
- exercised options over 2,171 shares of Mineralys TherapeuticsSEC Form 410 July 2026Common Stock · traded 9 July 2026 · filed 10 July 2026
- ▼ sold on the open market 2,171 shares of Mineralys TherapeuticsSEC Form 410 July 2026Common Stock · traded 9 July 2026 · filed 10 July 2026
- exercised options over 2,171 shares of Mineralys Therapeutics (a derivative holding)SEC Form 410 July 2026Stock Option · traded 9 July 2026 · filed 10 July 2026
- exercised options over 3,542 shares of Mineralys TherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- ▼ sold on the open market 9,890 shares of Mineralys TherapeuticsSEC Form 417 June 2026Common Stock · traded 15 June 2026 · filed 17 June 2026
- exercised options over 4,167 shares of Mineralys TherapeuticsSEC Form 417 June 2026Common Stock · traded 17 June 2026 · filed 17 June 2026
- exercised options over 417 shares of Mineralys TherapeuticsSEC Form 417 June 2026Common Stock · traded 17 June 2026 · filed 17 June 2026
- ▼ sold on the open market 4,584 shares of Mineralys TherapeuticsSEC Form 417 June 2026Common Stock · traded 17 June 2026 · filed 17 June 2026
- exercised options over 3,542 shares of Mineralys Therapeutics (a derivative holding)SEC Form 417 June 2026Stock Option · traded 15 June 2026 · filed 17 June 2026
- exercised options over 4,167 shares of Mineralys Therapeutics (a derivative holding)SEC Form 417 June 2026Stock Option · traded 17 June 2026 · filed 17 June 2026
- exercised options over 417 shares of Mineralys Therapeutics (a derivative holding)SEC Form 417 June 2026Stock Option · traded 17 June 2026 · filed 17 June 2026
- exercised options over 2,170 shares of Mineralys TherapeuticsSEC Form 412 June 2026Common Stock · traded 10 June 2026 · filed 12 June 2026
- ▼ sold on the open market 2,170 shares of Mineralys TherapeuticsSEC Form 412 June 2026Common Stock · traded 10 June 2026 · filed 12 June 2026
- exercised options over 6,349 shares of Mineralys TherapeuticsSEC Form 412 June 2026Common Stock · traded 12 June 2026 · filed 12 June 2026
- ▼ sold on the open market 6,349 shares of Mineralys TherapeuticsSEC Form 412 June 2026Common Stock · traded 12 June 2026 · filed 12 June 2026
- exercised options over 2,170 shares of Mineralys Therapeutics (a derivative holding)SEC Form 412 June 2026Stock Option · traded 10 June 2026 · filed 12 June 2026
- exercised options over 6,349 shares of Mineralys Therapeutics (a derivative holding)SEC Form 412 June 2026Stock Option · traded 12 June 2026 · filed 12 June 2026
- exercised options over 417 shares of Mineralys TherapeuticsSEC Form 419 May 2026Common Stock · traded 18 May 2026 · filed 19 May 2026
- ▼ sold on the open market 417 shares of Mineralys TherapeuticsSEC Form 419 May 2026Common Stock · traded 18 May 2026 · filed 19 May 2026
- exercised options over 417 shares of Mineralys Therapeutics (a derivative holding)SEC Form 419 May 2026Stock Option · traded 18 May 2026 · filed 19 May 2026
- exercised options over 2,171 shares of Mineralys TherapeuticsSEC Form 413 May 2026Common Stock · traded 11 May 2026 · filed 13 May 2026
- exercised options over 3,541 shares of Mineralys Therapeutics (a derivative holding)SEC Form 413 May 2026Stock Option · traded 13 May 2026 · filed 13 May 2026
- exercised options over 4,166 shares of Mineralys Therapeutics (a derivative holding)SEC Form 413 May 2026Stock Option · traded 13 May 2026 · filed 13 May 2026
- ▼ sold on the open market 2,171 shares of Mineralys TherapeuticsSEC Form 413 May 2026Common Stock · traded 11 May 2026 · filed 13 May 2026
- exercised options over 6,348 shares of Mineralys TherapeuticsSEC Form 413 May 2026Common Stock · traded 12 May 2026 · filed 13 May 2026
- ▼ sold on the open market 6,348 shares of Mineralys TherapeuticsSEC Form 413 May 2026Common Stock · traded 12 May 2026 · filed 13 May 2026
- exercised options over 3,541 shares of Mineralys TherapeuticsSEC Form 413 May 2026Common Stock · traded 13 May 2026 · filed 13 May 2026
- exercised options over 4,166 shares of Mineralys TherapeuticsSEC Form 413 May 2026Common Stock · traded 13 May 2026 · filed 13 May 2026
- ▼ sold on the open market 14,056 shares of Mineralys TherapeuticsSEC Form 413 May 2026Common Stock · traded 13 May 2026 · filed 13 May 2026
- exercised options over 2,171 shares of Mineralys Therapeutics (a derivative holding)SEC Form 413 May 2026Stock Option · traded 11 May 2026 · filed 13 May 2026
- exercised options over 6,348 shares of Mineralys Therapeutics (a derivative holding)SEC Form 413 May 2026Stock Option · traded 12 May 2026 · filed 13 May 2026
- exercised options over 416 shares of Mineralys TherapeuticsSEC Form 421 April 2026Common Stock · traded 17 April 2026 · filed 21 April 2026
- ▼ sold on the open market 416 shares of Mineralys TherapeuticsSEC Form 421 April 2026Common Stock · traded 17 April 2026 · filed 21 April 2026
- exercised options over 416 shares of Mineralys Therapeutics (a derivative holding)SEC Form 421 April 2026Stock Option · traded 17 April 2026 · filed 21 April 2026
- exercised options over 6,349 shares of Mineralys TherapeuticsSEC Form 415 April 2026Common Stock · traded 13 April 2026 · filed 15 April 2026
- exercised options over 3,542 shares of Mineralys TherapeuticsSEC Form 415 April 2026Common Stock · traded 13 April 2026 · filed 15 April 2026
- exercised options over 4,167 shares of Mineralys TherapeuticsSEC Form 415 April 2026Common Stock · traded 13 April 2026 · filed 15 April 2026
- ▼ sold on the open market 14,058 shares of Mineralys TherapeuticsSEC Form 415 April 2026Common Stock · traded 13 April 2026 · filed 15 April 2026
- ▼ sold on the open market 6,348 shares of Mineralys TherapeuticsSEC Form 415 April 2026Common Stock · traded 15 April 2026 · filed 15 April 2026
- exercised options over 6,349 shares of Mineralys Therapeutics (a derivative holding)SEC Form 415 April 2026Stock Option · traded 13 April 2026 · filed 15 April 2026
- exercised options over 3,542 shares of Mineralys Therapeutics (a derivative holding)SEC Form 415 April 2026Stock Option · traded 13 April 2026 · filed 15 April 2026
- exercised options over 4,167 shares of Mineralys Therapeutics (a derivative holding)SEC Form 415 April 2026Stock Option · traded 13 April 2026 · filed 15 April 2026
- exercised options over 2,170 shares of Mineralys TherapeuticsSEC Form 413 April 2026Common Stock · traded 9 April 2026 · filed 13 April 2026
- ▼ sold on the open market 2,170 shares of Mineralys TherapeuticsSEC Form 413 April 2026Common Stock · traded 9 April 2026 · filed 13 April 2026
- exercised options over 2,170 shares of Mineralys Therapeutics (a derivative holding)SEC Form 413 April 2026Stock Option · traded 9 April 2026 · filed 13 April 2026
- exercised options over 417 shares of Mineralys TherapeuticsSEC Form 417 March 2026Common Stock · traded 17 March 2026 · filed 17 March 2026
- ▼ sold on the open market 417 shares of Mineralys TherapeuticsSEC Form 417 March 2026Common Stock · traded 17 March 2026 · filed 17 March 2026
- exercised options over 417 shares of Mineralys Therapeutics (a derivative holding)SEC Form 417 March 2026Stock Option · traded 17 March 2026 · filed 17 March 2026
- exercised options over 417 shares of Mineralys Therapeutics (a derivative holding)SEC Form 417 March 2026Stock Option · traded 17 March 2026 · filed 17 March 2026
- exercised options over 417 shares of Mineralys TherapeuticsSEC Form 417 March 2026Common Stock · traded 17 March 2026 · filed 17 March 2026
- ▼ sold on the open market 417 shares of Mineralys TherapeuticsSEC Form 417 March 2026Common Stock · traded 17 March 2026 · filed 17 March 2026
- exercised options over 6,348 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- exercised options over 4,167 shares of Mineralys Therapeutics (a derivative holding)SEC Form 416 March 2026Stock Option · traded 13 March 2026 · filed 16 March 2026
- ▼ sold on the open market 6,348 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- exercised options over 3,542 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- exercised options over 6,348 shares of Mineralys Therapeutics (a derivative holding)SEC Form 416 March 2026Stock Option · traded 12 March 2026 · filed 16 March 2026
- exercised options over 3,542 shares of Mineralys Therapeutics (a derivative holding)SEC Form 416 March 2026Stock Option · traded 13 March 2026 · filed 16 March 2026
- exercised options over 4,167 shares of Mineralys Therapeutics (a derivative holding)SEC Form 416 March 2026Stock Option · traded 13 March 2026 · filed 16 March 2026
- exercised options over 4,167 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- ▼ sold on the open market 10,726 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- ▼ sold on the open market 3,079 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- ▼ sold on the open market 253 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- exercised options over 6,348 shares of Mineralys Therapeutics (a derivative holding)SEC Form 416 March 2026Stock Option · traded 12 March 2026 · filed 16 March 2026
- exercised options over 6,348 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- ▼ sold on the open market 6,348 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 12 March 2026 · filed 16 March 2026
- exercised options over 3,542 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- exercised options over 4,167 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- ▼ sold on the open market 10,726 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- ▼ sold on the open market 3,079 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- ▼ sold on the open market 253 shares of Mineralys TherapeuticsSEC Form 416 March 2026Common Stock · traded 13 March 2026 · filed 16 March 2026
- exercised options over 3,542 shares of Mineralys Therapeutics (a derivative holding)SEC Form 416 March 2026Stock Option · traded 13 March 2026 · filed 16 March 2026
- exercised options over 2,171 shares of Mineralys TherapeuticsSEC Form 410 March 2026Common Stock · traded 9 March 2026 · filed 10 March 2026
- ▼ sold on the open market 2,171 shares of Mineralys TherapeuticsSEC Form 410 March 2026Common Stock · traded 9 March 2026 · filed 10 March 2026
- exercised options over 2,171 shares of Mineralys Therapeutics (a derivative holding)SEC Form 410 March 2026Stock Option · traded 9 March 2026 · filed 10 March 2026
- exercised options over 2,171 shares of Mineralys Therapeutics (a derivative holding)SEC Form 410 March 2026Stock Option · traded 9 March 2026 · filed 10 March 2026
- exercised options over 2,171 shares of Mineralys TherapeuticsSEC Form 410 March 2026Common Stock · traded 9 March 2026 · filed 10 March 2026
- ▼ sold on the open market 2,171 shares of Mineralys TherapeuticsSEC Form 410 March 2026Common Stock · traded 9 March 2026 · filed 10 March 2026
- was granted 38,400 shares of Mineralys TherapeuticsSEC Form 420 February 2026Common Stock · traded 19 February 2026 · filed 20 February 2026
- was granted 51,300 shares of Mineralys Therapeutics (a derivative holding)SEC Form 420 February 2026Stock Option · traded 19 February 2026 · filed 20 February 2026
- was granted 51,300 shares of Mineralys Therapeutics (a derivative holding)SEC Form 420 February 2026Stock Option · traded 19 February 2026 · filed 20 February 2026
- was granted 38,400 shares of Mineralys TherapeuticsSEC Form 420 February 2026Common Stock · traded 19 February 2026 · filed 20 February 2026
- exercised options over 417 shares of Mineralys TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 417 shares of Mineralys TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- exercised options over 417 shares of Mineralys Therapeutics (a derivative holding)SEC Form 417 February 2026Stock Option · traded 17 February 2026 · filed 17 February 2026
- exercised options over 417 shares of Mineralys Therapeutics (a derivative holding)SEC Form 417 February 2026Stock Option · traded 17 February 2026 · filed 17 February 2026
- exercised options over 417 shares of Mineralys TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- ▼ sold on the open market 417 shares of Mineralys TherapeuticsSEC Form 417 February 2026Common Stock · traded 17 February 2026 · filed 17 February 2026
- exercised options over 6,349 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 12 February 2026 · filed 13 February 2026
- exercised options over 3,541 shares of Mineralys Therapeutics (a derivative holding)SEC Form 413 February 2026Stock Option · traded 13 February 2026 · filed 13 February 2026
- exercised options over 4,166 shares of Mineralys Therapeutics (a derivative holding)SEC Form 413 February 2026Stock Option · traded 13 February 2026 · filed 13 February 2026
- ▼ sold on the open market 5,828 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 12 February 2026 · filed 13 February 2026
- ▼ sold on the open market 521 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 12 February 2026 · filed 13 February 2026
- exercised options over 6,349 shares of Mineralys Therapeutics (a derivative holding)SEC Form 413 February 2026Stock Option · traded 12 February 2026 · filed 13 February 2026
- exercised options over 3,541 shares of Mineralys Therapeutics (a derivative holding)SEC Form 413 February 2026Stock Option · traded 13 February 2026 · filed 13 February 2026
- exercised options over 4,166 shares of Mineralys Therapeutics (a derivative holding)SEC Form 413 February 2026Stock Option · traded 13 February 2026 · filed 13 February 2026
- exercised options over 3,541 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 13 February 2026 · filed 13 February 2026
- ▼ sold on the open market 3,541 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 13 February 2026 · filed 13 February 2026
- exercised options over 4,166 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 13 February 2026 · filed 13 February 2026
- ▼ sold on the open market 4,166 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 13 February 2026 · filed 13 February 2026
- ▼ sold on the open market 6,348 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 13 February 2026 · filed 13 February 2026
- exercised options over 6,349 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 12 February 2026 · filed 13 February 2026
- ▼ sold on the open market 5,828 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 12 February 2026 · filed 13 February 2026
- ▼ sold on the open market 521 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 12 February 2026 · filed 13 February 2026
- exercised options over 3,541 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 13 February 2026 · filed 13 February 2026
- ▼ sold on the open market 3,541 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 13 February 2026 · filed 13 February 2026
- exercised options over 4,166 shares of Mineralys TherapeuticsSEC Form 413 February 2026Common Stock · traded 13 February 2026 · filed 13 February 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.